- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/216 - Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
Patent holdings for IPC class A61K 31/216
Total number of patents in this class: 2275
10-year publication summary
166
|
235
|
194
|
202
|
220
|
171
|
211
|
226
|
158
|
45
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Sichuan Jiuzhang Biological Science and Technology Co., Ltd | 64 |
55 |
Novartis AG | 11238 |
27 |
Kao Corporation | 4843 |
27 |
io Therapeutics, Inc. | 112 |
26 |
Allergan, Inc. | 2600 |
21 |
Apnimed, Inc. (Delaware) | 35 |
20 |
United Therapeutics Corporation | 291 |
19 |
Corsair Pharma, Inc. | 35 |
15 |
Sichuan Jiuzhang Bio-technology Co., Ltd. | 15 |
15 |
The Regents of the University of California | 18943 |
14 |
Horizon Therapeutics, LLC | 25 |
14 |
Infirst Healthcare Limited | 60 |
14 |
Yissum Research Development Company of The Hebrew University of Jerusalem Ltd. | 1338 |
14 |
Hisamitsu Pharmaceutical Co., Inc. | 792 |
13 |
Mati Therapeutics Inc. | 68 |
13 |
Genfit | 257 |
12 |
The Research Foundation for The State University of New York | 1468 |
12 |
Tris Pharma, Inc. | 91 |
12 |
Société des Produits Nestlé S.A. | 9672 |
11 |
Insmed Incorporated | 207 |
10 |
Other owners | 1911 |